Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Tumor Grade 1”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT03879694
What this trial is testing

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Lung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor
Roswell Park Cancer Institute 19
Not applicableStudy completedNCT03616431
What this trial is testing

Pancreatic Cancer Dietary Assessment Study

Who this might be right for
Pancreatic NeoplasmPancreas AdenocarcinomaWell-Differentiated Neuroendocrine Carcinoma+1 more
The Christie NHS Foundation Trust 112
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Not applicableLooking for participantsNCT04464122
What this trial is testing

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Who this might be right for
Neuroendocrine TumorsNeuroendocrine NeoplasmNeuroendocrine Tumor Grade 1+2 more
University of Roma La Sapienza 60
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableLooking for participantsNCT04278118
What this trial is testing

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Who this might be right for
Grade I MeningiomaGrade II MeningiomaGrade III Meningioma+4 more
Emory University 70
Early research (Phase 1)Looking for participantsNCT07114939
What this trial is testing

FTT PET/CT in Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Carcinoma MetastaticPancreatic Tumors
Abramson Cancer Center at Penn Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT07357623
What this trial is testing

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Who this might be right for
Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital 96
Early research (Phase 1)Ended earlyNCT03014297
What this trial is testing

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Who this might be right for
Neuroendocrine TumorsEverolimus
Lowell Anthony, MD 17
Large-scale testing (Phase 3)Looking for participantsNCT06855095
What this trial is testing

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2+1 more
The Netherlands Cancer Institute 39
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03728361
What this trial is testing

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Who this might be right for
Grade I Neuroendocrine CarcinomaGrade II Neuroendocrine CarcinomaGrade III Neuroendocrine Carcinoma+9 more
Dwight Owen 55
Post-approval studies (Phase 4)UnknownNCT03083210
What this trial is testing

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Who this might be right for
Neuroendocrine Tumors
Samsung Medical Center 28
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Very early researchActive Not RecruitingNCT05111509
What this trial is testing

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

Who this might be right for
Neuroendocrine Tumor Grade 2Neuroendocrine Tumor Grade 1
Yusuf Menda 20
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Large-scale testing (Phase 3)Study completedNCT04852679
What this trial is testing

Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 43
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Load More Results